Retractable Technologies, Inc.  

(Public, NYSEMKT:RVP)   Watch this stock  
Find more results for NYSEAMEX:RVP
+0.04 (1.02%)
Apr 17 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 3.50 - 3.58
52 week 1.10 - 4.10
Open 3.50
Vol / Avg. 0.00/35,985.00
Mkt cap 97.17M
P/E     -
Div/yield     -
EPS -0.30
Shares 27.30M
Beta 0.81
Inst. own 3%

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin -10.27% -12.28%
Operating margin -9.01% -11.71%
EBITD margin - -7.74%
Return on average assets -8.21% -8.56%
Return on average equity -15.81% -13.96%
Employees 156 -
CDP Score - -


511 Lobo Lane
LITTLE ELM, TX 75068-0009
United States - Map
+1-972-2941010 (Phone)
+1-972-2923600 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Retractable Technologies, Inc. is engaged in the business of designing, developing, manufacturing and marketing of patented safety medical products for the healthcare industry. VanishPoint products retract the needle directly from the patient, reducing exposure to the contaminated needle. The Company�s VanishPoint safety needle products consist of one milliliter tuberculin, insulin, and allergy antigen VanishPoint syringes; 0.5 milliliter, two milliliter, three milliliter, five milliliter, and 10 milliliter VanishPoint syringes; the VanishPoint blood collection tube holder; autodisable syringe, and the VanishPoint IV safety catheter. The Company also has a Patient Safe syringe which is designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The Company is selling autodisable syringes in the international market in addition to its other products.

Officers and directors

Thomas J. Shaw Chairman of the Board, President, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Douglas W. Cowan Chief Financial Officer, Vice President, Principal Accounting Officer, Treasurer, Director
Age: 70
Bio & Compensation  - Reuters
Steven R. Wisner Executive Vice President - Engineering & Production, Director
Age: 56
Bio & Compensation  - Reuters
Michele M. Larios Vice President, General Counsel, Secretary
Age: 47
Bio & Compensation  - Reuters
Russell B. Kuhlman Vice President - Sales
Age: 59
Bio & Compensation  - Reuters
Walter O. Bigby Jr. Independent Director
Age: 48
Bio & Compensation  - Reuters
Marco Laterza Independent Director
Age: 65
Bio & Compensation  - Reuters
Amy Mack Independent Director
Age: 45
Bio & Compensation  - Reuters
Clarence Zierhut Independent Director
Age: 85
Bio & Compensation  - Reuters